Genesco Inc (GCO)
Official siteCONSUMER CYCLICAL • APPAREL RETAIL • NYSE
Market Cap: $384.01M
Last updated: Nov 17, 2026 at 11:05 AM ET
Genesco Inc (GCO) Earnings: Report Dates and Results
Genesco (GCO) is expected to report earnings on Nov 27, 2026. In the quarter ended Jul 31, 2026, Genesco reported EPS of -$0.83, above the -$1.34 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GCO has an expected report date of Nov 27, 2026. Analysts' consensus for the quarter ended Oct 31, 2026 is 17.7% above the $0.79 reported for the quarter ended Oct 31, 2025.
GCO Earnings Call
The latest GCO earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 38 quarters below that had an estimate, GCO beat 27 and missed 11. Revenue for the quarter ended Jul 31, 2026 was $529.86M, down 3.0% from $545.97M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | -$0.83 | -$1.34 | N/A | +38.06% | Beat | N/A | 3 | 1 up, 3 down | Sep 3, 2026 | $529.86M |
| Apr 30, 2026 | -$2.18 | -$2.57 | -$2.62 - -$2.47 | +15.18% | Beat | N/A | 4 | 0 up, 2 down | May 29, 2026 | $487.02M |
| Jan 31, 2026 | $3.74 | $3.59 | N/A | +4.18% | Beat | +14.7% | N/A | N/A | Mar 6, 2026 | $799.94M |
| Oct 31, 2025 | $0.79 | $0.86 | $0.85 - $0.88 | -8.14% | Miss | +29.5% | 3 | 0 up, 2 down | Dec 4, 2025 | $616.22M |
| Jul 31, 2025 | -$1.14 | -$1.25 | -$1.28 - -$1.23 | +8.80% | Beat | N/A | 3 | 0 up, 2 down | Aug 28, 2025 | $545.97M |
| Apr 30, 2025 | -$2.05 | -$2.09 | N/A | +1.91% | Beat | N/A | 2 | 1 up, 1 down | Jun 4, 2025 | $473.97M |
| Jan 31, 2025 | $3.26 | $3.31 | $3.26 - $3.35 | -1.51% | Miss | +25.9% | 2 | 2 up, 0 down | Mar 7, 2025 | $745.95M |
| Oct 31, 2024 | $0.61 | $0.30 | $0.22 - $0.37 | +103.33% | Beat | +7.0% | 2 | 1 up, 0 down | Dec 6, 2024 | $596.33M |
| Jul 31, 2024 | -$0.83 | -$1.11 | -$1.15 - -$1.08 | +25.23% | Beat | N/A | 2 | 1 up, 0 down | Sep 6, 2024 | $525.19M |
| Apr 30, 2024 | -$2.10 | -$2.66 | -$2.70 - -$2.62 | +21.05% | Beat | N/A | 2 | 1 up, 0 down | May 31, 2024 | $457.60M |
| Jan 31, 2024 | $2.59 | $2.62 | N/A | -1.15% | Miss | -15.4% | 3 | 0 up, 0 down | Mar 8, 2024 | $738.95M |
| Oct 31, 2023 | $0.57 | $0.84 | $0.82 - $0.85 | -32.14% | Miss | -65.5% | 2 | 1 up, 0 down | Dec 1, 2023 | $579.32M |
| Jul 31, 2023 | -$0.85 | -$1.23 | -$1.25 - -$1.21 | +30.89% | Beat | -244.1% | 2 | 0 up, 0 down | Aug 31, 2023 | $523.03M |
| Apr 30, 2023 | -$1.59 | -$1.10 | -$1.16 - -$1.04 | -44.55% | Miss | -461.4% | 2 | 0 up, 1 down | May 25, 2023 | $483.33M |
| Jan 31, 2023 | $3.06 | $3.00 | $3.00 - $3.04 | +2.00% | Beat | -12.1% | 2 | 0 up, 0 down | Mar 9, 2023 | $725.02M |
| Oct 31, 2022 | $1.65 | $1.57 | $1.56 - $1.58 | +5.10% | Beat | -30.1% | 3 | 1 up, 0 down | Dec 2, 2022 | $603.79M |
| Jul 31, 2022 | $0.59 | $0.26 | $0.18 - $0.39 | +126.92% | Beat | -43.8% | 3 | 0 up, 1 down | Sep 1, 2022 | $535.33M |
| Apr 30, 2022 | $0.44 | -$0.09 | -$0.18 - -$0.04 | +588.89% | Beat | -44.3% | 3 | 0 up, 0 down | May 26, 2022 | $520.75M |
| Jan 31, 2022 | $3.48 | $2.65 | $2.61 - $2.67 | +31.32% | Beat | +26.1% | 3 | 1 up, 0 down | Mar 10, 2022 | $727.66M |
| Oct 31, 2021 | $2.36 | $1.29 | $1.20 - $1.35 | +82.95% | Beat | +177.6% | 3 | 0 up, 0 down | Dec 3, 2021 | $600.55M |
| Jul 31, 2021 | $1.05 | $0.03 | -$0.02 - $0.10 | N/A | N/A | N/A | 4 | N/A | Sep 2, 2021 | $555.18M |
| Apr 30, 2021 | $0.79 | -$0.52 | -$0.62 - -$0.38 | +251.92% | Beat | N/A | 4 | N/A | May 27, 2021 | $538.70M |
| Jan 31, 2021 | $2.76 | $1.96 | $1.88 - $2.00 | +40.82% | Beat | -10.7% | 4 | N/A | Mar 11, 2021 | $636.80M |
| Oct 31, 2020 | $0.85 | -$0.14 | -$0.53 - $0.16 | +707.14% | Beat | -36.1% | 5 | N/A | Dec 4, 2020 | $479.28M |
| Jul 31, 2020 | -$1.23 | -$1.85 | -$2.84 - -$1.24 | +33.51% | Beat | -920.0% | 5 | N/A | Sep 3, 2020 | $391.22M |
| Apr 30, 2020 | -$3.65 | -$2.52 | -$4.00 - -$1.39 | -44.84% | Miss | -1206.1% | 5 | N/A | Jun 9, 2020 | $279.23M |
| Jan 31, 2020 | $3.09 | $2.74 | $2.71 - $2.77 | +12.77% | Beat | +41.7% | 5 | N/A | Mar 12, 2020 | $677.58M |
| Oct 31, 2019 | $1.33 | $1.08 | $1.02 - $1.17 | +23.15% | Beat | +40.0% | 5 | N/A | Dec 6, 2019 | $537.26M |
| Jul 31, 2019 | $0.15 | -$0.01 | -$0.08 - $0.03 | N/A | N/A | +275.0% | 6 | N/A | Sep 6, 2019 | $486.57M |
| Apr 30, 2019 | $0.33 | $0.03 | $0.02 - $0.10 | +1000.00% | Beat | N/A | 6 | N/A | May 31, 2019 | $495.65M |
| Jan 31, 2019 | $2.18 | $2.33 | $2.29 - $2.38 | -6.44% | Miss | +1.4% | 6 | N/A | Mar 14, 2019 | $675.49M |
| Oct 31, 2018 | $0.95 | $0.86 | $0.75 - $0.94 | +10.47% | Beat | -6.9% | 7 | N/A | Dec 6, 2018 | $539.83M |
| Jul 31, 2018 | $0.04 | -$0.03 | -$0.05 - $0.00 | +233.33% | Beat | N/A | 8 | N/A | Sep 7, 2018 | $487.01M |
| Apr 30, 2018 | -$0.06 | -$0.04 | -$0.34 - $0.04 | -50.00% | Miss | -200.0% | 8 | N/A | Jun 5, 2018 | $486.22M |
| Jan 31, 2018 | $2.15 | $2.09 | $2.07 - $2.12 | +2.87% | Beat | 0.0% | 9 | N/A | Mar 15, 2018 | $150.91M |
| Oct 31, 2017 | $1.02 | $1.12 | $0.93 - $1.22 | -8.93% | Miss | -20.3% | 8 | N/A | Dec 1, 2017 | $716.76M |
| Jul 31, 2017 | -$0.10 | -$0.08 | -$0.21 - $0.00 | -25.00% | Miss | -129.4% | 9 | N/A | Aug 31, 2017 | $616.51M |
| Apr 30, 2017 | $0.06 | $0.27 | $0.19 - $0.43 | -77.78% | Miss | -90.3% | 10 | N/A | May 25, 2017 | $643.37M |
| Jan 31, 2017 | $2.15 | $1.78 | N/A | +20.79% | Beat | +1.9% | N/A | N/A | Mar 10, 2017 | $35.66M |
| Oct 31, 2016 | $1.28 | $0.93 | N/A | +37.63% | Beat | -8.6% | N/A | N/A | Dec 2, 2016 | $710.82M |
Annual EPS
EPS for the fiscal year ended Jan 31, 2026 was $1.34, up 42.6% from the year before. It was $4.39 for the year ended Jan 31, 2017, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jan 31, 2026 | $1.34 | +42.6% |
| Jan 31, 2025 | $0.94 | +30.6% |
| Jan 31, 2024 | $0.72 | -87.5% |
| Jan 31, 2023 | $5.74 | -25.3% |
| Jan 31, 2022 | $7.68 | N/A |
| Jan 31, 2021 | -$1.27 | -125.9% |
| Jan 31, 2020 | $4.90 | +57.6% |
| Jan 31, 2019 | $3.11 | N/A |
| Jan 31, 2018 | $3.13 | -28.7% |
| Jan 31, 2017 | $4.39 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 5,900 words across 7 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 5,923 | 7 | |
| 2026Q2 | Jun 30, 2026 | 6,246 | 7 | |
| 2026Q1 | Mar 31, 2026 | 7,358 | 7 | |
| 2025Q4 | Dec 31, 2025 | 7,561 | 6 | |
| 2025Q3 | Sep 30, 2025 | 7,099 | 7 | |
| 2025Q2 | Jun 30, 2025 | 6,431 | 6 | |
| 2025Q1 | Mar 31, 2025 | 6,979 | 6 | |
| 2024Q4 | Dec 31, 2024 | 7,245 | 7 |
2026Q3 Earnings Call
Opening remarks
Jason Ware Vice President, Finance and Investor Relations Good morning, everyone, and thank you for joining us to discuss our third quarter fiscal 2026 results. Participants on the call expect to make forward-looking statements reflecting our expectations as of today. Actual results could be different. Genesco refers you to this morning's earnings release and the company's SEC filings, including its most recent 10-Ks and 10-Q filings, for some of the factors that could cause differences from the expectations reflected in the forward-looking statements made today. Participants also expect to refer to certain adjusted financial measures during the call. All non-GAAP financial measures are reconciled to their GAAP counterparts in the attachments to this morning's press release and in schedules available on the company's website in the Quarterly Results section. We have also posted a presentation summarizing our results here as well. With me on the call today is Mimi Eckel Vaughn, Board Chair, President, and Chief Executive Officer, and Sandra Harris, Senior Vice President, Finance, and Chief Financial Officer. I'd like to turn the call over to Mimi. Thanks, Jason.
Mimi Eckel Vaughn Board Chair, President and Chief Executive Officer (CEO) Good morning, everyone. And thank you for joining us on our third quarter earnings call. We delivered solid performance versus last year in this important back-to-school quarter led by Journeys, which achieved 6% comp growth and more than a 50% increase in operating income. This significant improvement in profitability was partially offset by the anticipated exit of licenses in Genesco Brands Group, the impact of tariffs, and more-than-expected gross margin pressure at Schuh as the UK market faced heightened promotional activity. Against this backdrop, we delivered our fifth consecutive quarter of positive comp sales growth overall and third quarter results within our expectations, albeit at the lower end, reflecting both the strength and resilience of our portfolio in a dynamic consumer environment. Total comparable sales increased 3% with store comps up a noteworthy 5%, coupled with a modest decline in e-commerce comp, which faced tougher comparisons against last year's double-digit gains. These results reflect our investment in the store channel and the strength of our in-store experience supported by well-executed assortments and engaged teams that continue to drive conversion. The consumer environment continues to reflect customers shopping when there's a reason and pulling back when there's not. This pattern became much more pronounced for our category during back-to-school this year, which is factoring into our view of the fourth quarter. In the third quarter, demand was even stronger than we expected during the heart of back-to-school, and then traffic and purchase intent softened considerably and more than we expected in the weeks following with an especially challenging October. Customers are searching for must-have items and newness and freshness to drive their purchases.
Frequently Asked Questions About GCO
When is Genesco's next earnings date?
Genesco's next earnings report is expected for Nov 27, 2026.
Did GCO beat earnings estimates last quarter?
Yes. Genesco reported EPS of -$0.83 for the quarter ended Jul 31, 2026, above the -$1.34 estimate, a 38.06% surprise.
What EPS do analysts expect from GCO next quarter?
The consensus EPS estimate for Genesco for the quarter ended Oct 31, 2026 is $0.93 from 4 analysts, with estimates from $0.91 to $0.94.
How often does GCO beat earnings estimates?
Genesco beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +20.23%.
GCO pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors